baber/WOPTO huggingface dataset:
Patent AU-2019273951-A1 (AU)
Title: Dehumidification structure
Inventor: NAKAMURA TAKUJU
IPC: F24F3/14
Filed: 2019-04-10
Abstract: This dehumidification structure (1) is provided with: a moisture absorbent (10) that has temperature sensitivity for exhibiting hydrophobicity and releasing water at temperature equal to or higher than a predetermined temperature and for exhibiting hydrophilicity and absorbing water at a temperature lower than the predetermined temperature; and a water draining mechanism (40) for draining the water released by the moisture absorbent (10) and accumulated in a moisture absorbent chamber (MR). The moisture absorbent (10) is provided so as to be able to receive solar heat, and the water draining mechanism (40) uses the weight of the water to drain the water when the amount of water released by the moisture absorbent (10) and accumulated in the moisture absorbent chamber (MR) reaches at least a predetermined amount.
Patent AU-2019278013-A1 (AU)
Title: Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof
Inventor: CHEN LI
IPC: A61K31/497
Filed: 2019-05-28
Abstract: A pharmaceutical combination. The pharmaceutical combination contains a glucokinase activator or a pharmaceutically acceptable salt thereof, an isotopic marker thereof, a crystalline form thereof, a hydrate, a solvate, a diastereoisomer or an enantiomer form, and a biguanide hypoglycemic drug. A pharmaceutical composition and a fixed dose combination preparation as well as a preparation method and use of the pharmaceutical composition and the fixed dose combination preparation.
Patent AU-2019281727-A1 (AU)
Title: Needle position indicator
Inventor: ISAACSON S RAY
IPC: A61M25/06
Filed: 2019-05-13
Abstract: A catheter system (100), having a catheter adapter (110) with a proximal end, a distal end (114), and an interior extending therebetween. An intravenous catheter (140) coupled to the distal end of the catheter adapter and including a lumen. A central pathway (132) in fluid communication with the interior of the catheter adapter and the lumen of the intravenous catheter. An interface surface (118) comprising a portion of the central pathway. An introducer needle (120) positioned within the central pathway and having a distal end (122) comprising a distal opening, a proximal end, and a body extending therebetween and an indicator (180) provided on an outer surface of the introducer needle and having a distal end spaced from the distal opening a distance that is greater than a distance between the proximal end of the catheter adapter and the interface surface.
Patent AU-2019289150-A1 (AU)
Title: Systems and methods for automating customer interactions with enterprises
Inventor: KONIG YOCHAI
IPC: H04M3/523
Filed: 2019-06-17
Abstract: A method for automating interactions with enterprises includes: receiving, through a user interface, a natural language request from a customer; determining a customer intent from the natural language request; conducting an automated interaction by: determining, by a personal bot controller circuit, an enterprise to service the customer intent; loading an enterprise library for interacting with an application programming interface (API) of the enterprise, the enterprise library including one or more library functions; identifying a library function for servicing the customer intent from among the one or more library functions; generating a request based on the identified library function and the customer intent; transmitting the generated request to the enterprise to initiate an interaction; receiving a response from the enterprise; and notifying the customer of a result of the interaction.
Patent AU-2019289216-A1 (AU)
Title: Oxadiazoles as agonists of the muscarinic M1 and/or M4 receptor
Inventor: BROWN GILES ALBERT
IPC: A61P25/28
Filed: 2019-06-24
Abstract: This invention relates to compounds that are agonists of the muscarinic M
Patent AU-2019340456-A1 (AU)
Title: Epitopes
Inventor: XUE WEI
IPC: C07K14/47
Filed: 2019-09-11
Abstract: The present invention relates to epitopes containing homocitrulline (Hcit) that can be used as targets for cancer immunotherapy. The homocitrullinated T cell epitope has (i) a predicted binding score to MHC class II or class I of < 30 using the online IEDB prediction program (http://www.iedb.org/) and (ii) at least 5 consecutive amino acids that form a spiral conformational structure. These modified peptides can be used as vaccines or as targets for T cell receptor (TCR) and adoptive T cell transfer therapies.
Patent AU-2019356040-A1 (AU)
Title: Bullet having a negative Poisson’s ratio effect and a design method thereof
Inventor: REN XIN
IPC: F42B30/02
Filed: 2019-01-10
Abstract: The present invention discloses a bullet having a negative Poisson's ratio effect and a design 
method thereof. The bullet includes a cylindrical bullet section having a negative Poisson's 
ratio design, as well as a conical bullet tail and a bullet tip each with a matching design; the 
cylindrical bullet section is a tubular structure having periodically alternating transverse and 
vertical holes; the tubular structure includes a number of holes, with a center axis of one hole 
being axially perpendicular to a center axis of another adjacent hole, that is, the axis of each 
hole being structurally orthogonal to an adjacent hole; and the holes in rows and columns are 
periodically arranged into the tubular structure, which is a tubular structure having the 
negative Poisson's ratio effect. The bullet designed with the method of the present invention 
has a larger negative Poisson's ratio effect, and has the characteristics of reducing the energy 
lost due to frictions between a bullet and a gun barrel, which allows the bullet to have a higher 
initial velocity and a stronger penetrating power, and greatly increases the service life of the 
gun barrel, thereby better meeting the actual needs.  
9
Patent AU-2019376368-A1 (AU)
Title: Amorphous solid dispersion comprising 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide
Inventor: CHEN XIANGYANG
IPC: A61K31/455
Filed: 2019-10-28
Abstract: An amorphous solid dispersion comprises 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl) nicotinamide (Compound I) or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable polymer. Also provided is pharmaceutical compositions comprising the amorphous solid dispersion, which is stable upon storage and provides a better dissolution rate and bioavailability when comparing with a crystalline form.
Patent AU-2019384147-A1 (AU)
Title: A method to measure tissue texture using NMR spectroscopy with VOI length in an analysis direction defined by receiver bandwidth
Inventor: JAMES TIMOTHY W
IPC: A61B5/055
Filed: 2019-11-20
Abstract: A method for selective sampling to assess texture of a specimen using magnetic resonance (MR) excites the specimen and refocuses to provide a sample rod within the specimen. An encoding gradient pulse is applied to induce phase wrap creating a spatial encode for a specific k-value and orientation. A low non-zero magnitude gradient (140) is then applied acting as a time dependent phase encode to produce a time varying trajectory through 3D k- space of k-value encodes (146) while simultaneously recording multiple sequential samples (138) of the signal at a sequence of k-values proximate the specific k-value. The receiver bandwidth is set to delineate a length of a VOI within the rod during the data sampling. The samples are then post processed at the sequence of k values, recorded within a time span while the non-zero magnitude gradient is applied, to characterize the textural features of tissue in the VOI.
Patent AU-2019402034-A1 (AU)
Title: Obscuration cloud generator
Inventor: MERON SERGEY
IPC: G08B15/02
Filed: 2019-12-18
Abstract: An obscuration cloud generation device (100) comprises a housing (101) having a door (102) and a frame (103) sized and shaped to accommodate an obscuration cloud generating canister (110) when the door (102) is in a closed state. Activation of the canister (110) emits a composition for forming the cloud. The door (102) has an operably open state in which the door (102) is open at least a predefined minimum extent for exiting of the emitted composition. A door checking system (104) applies a force for opening the door (102) and generates an indication of whether the door (102) is open at least to the minimum extent. A controller (105) is adapted to instruct the checking system (104) to apply the force and to receive the indication to determine, before activating the canister (110), that the door (102) is not blocked from reaching the operably open state.
Patent WO-2021000005-A1 (WO)
Inventor: SALISBURY TIMOTHY
IPC: B65B11/04
Filed: 2020-07-02
Abstract: The present invention relates to wrapping palletised items and loads. A method, system and apparatus is disclosed for stretch wrapping which provides a device adapted to provide strips of material of various widths, the device comprising: one or more blades for slitting a film of material to form two or more strips, a primary guide for guiding the two or more strips, a secondary guide, over which the strips pass, and two or more shaped recesses operatively associated with one of the primary guide or the secondary guide, each recess guiding a strip, wherein the width of the strips can be varied by altering the relative positions of the primary guide and secondary guide.
Patent AU-2020201489-A1 (AU)
Title: Improved T cell compositions
Inventor: FRIEDMAN KEVIN
IPC: A01N63/00
Filed: 2020-02-28
Abstract: The invention provides improved T cell compositions and methods for manufacturing T cells. More particularly, the invention provides methods of T cell manufacturing that result in adoptive T cell immunotherapies with improved survival, expansion, and persistence in vivo.
Patent AU-2020202420-A1 (AU)
Title: Seal assemblies for surgical access assemblies
Inventor: EBERSOLE GARRETT
IPC: A61B17/34
Filed: 2020-04-07
Abstract: SEAL ASSEMBLIES FOR SURGICAL ACCESS ASSEMBLIES 
ABSTRACT 
An access assembly (100) comprising: an instrument valve housing (110) including upper 
and lower housing sections (112, 114) and defining a cavity; and a valve assembly (120) 
disposed within the cavity of the instrument valve housing (110), the valve assembly (120) 
including: a guard assembly (140) including a plurality of guard sections, and a seal assembly 
(160) disposed adjacent to the guard assembly (140), the seal assembly (160) including first, 
second, third, and fourth seal sections (162, 164, 166, 168), wherein the first seal section (162) is 
nested within the second seal section (164), the first and second seal sections (162, 164) are 
nested within the third seal section (166), and the first, second, and third seal sections (162, 164, 
166) are nested within the fourth seal section (168).
2/7 
182 120 
10 
1801 146 
F18.60 
FIG. 2
Patent AU-2020204377-A1 (AU)
Title: Methods and apparatus to control vehicle steering
Inventor: ROBINSON WILLIAM DANIEL
IPC: B60W30/10
Filed: 2020-06-30
Abstract: Methods, apparatus, systems and articles of manufacture are disclosed that 
control vehicle steering. An example apparatus includes: a path acquisition 
interface configured to obtain, via a user interface a sampling interval; and a 
controller configured to, during acquisition mode: determine a steering angle of a 
wheel of the vehicle based on a trigonometric function including a distance 
associated with a turn radius of the front wheel; and cause, utilizing the steering 
angle, a global navigation satellite system (GNSS) receiver to travel from a first 
position to a second position, the GNSS receiver located at the first position at a 
first sampling time and the second position at a second sampling time, the first 
sampling time and the second sampling time differing by the sampling interval.  
- 88-
Patent AU-2020231452-A1 (AU)
Title: Work vehicle
Inventor: NISHIKUBO TAKUYA
IPC: G01S15/93
Filed: 2020-02-05
Abstract: Provided is a work vehicle (1) that facilitates mounting of an obstacle detector (84) for detecting an obstacle that impedes travel and of a lamp, and that allows a reduction in costs. The work vehicle (1) is provided with: a vehicle body (5); the obstacle detector (84) for detecting an obstacle around the vehicle body (5); a lamp that lights up around the vehicle body (5); and a mounting bracket (85) that is mounted on the vehicle body. The mounting bracket (85) has a mounting body (86) including a detector mounting section (87) to which the obstacle detector (84) is mounted, and a lamp mounting section to which the lamp is mounted.
Patent AU-2020233626-A1 (AU)
Title: Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
Inventor: MANTZOROS CHRISTOS
IPC: A61K31/47
Filed: 2020-09-14
Abstract: The present invention relates to methods for treating a disease associated with insulin 
resistance selected from a nonalcoholic fatty liver disease (NAFLD) and its sequelae, a 
lipodystrophic syndrome or a combination thereof with the selective PPARy agonist, INT131 
and optionally vitamin E or compositions thereof. NAFLDs that may be treated with methods 
and compositions of the present invention include, but are not limited to, simple nonalcoholic 
fatty liver and nonalcoholic steatohepatitis (NASH). Lipodystrophic syndromes that may be 
treated with the methods and compositions of the present invention include, but are not limited 
to, generalized lipodystrophy including congenital generalized lipodystrophy and acquired 
generalized lipodystrophy and/or partial lipodystrophy, including congenital partial 
lipodystrophy and acquired partial lipodystrophy, all of which may or may not include 
hyperlipidemia and/or hyperglycemia and may or may not include NAFLD.
Patent AU-2020244368-A1 (AU)
Title: Generation of binding molecules
Inventor: THROSBY MARK
IPC: C12N15/13
Filed: 2020-09-28
Abstract: The present invention provides a method to efficiently and comprehensively interrogate the 
broad spectrum of antibodies generated by B cell populations. The invention provides a 
method for producing a defined population of binding molecules, said method comprises at 
5 least the following steps: a) providing a population of B cells expressing a limited VL 
repertoire wherein essentially all of said B cells carry at least one VL, b) obtaining nucleic 
acids (RNA or DNA) from said B cells, c) optionally, amplification of nucleic acid sequences 
encoding immunoglobulin heavy chain variable regions in said sample, d) at least partial 
sequencing of all obtained nucleic acids of step b) or the amplification products of step c), e) 
0 performing a frequency analysis of sequences from step d), f) selecting desired VH 
sequences, g) providing a host cell with at least one vector comprising at least one of said 
desired VH sequences and/or at least one VL sequence of said limited VL repertoire, h) 
culturing said host cells and allowing for expression of VH and/or VL polypeptides, i) 
obtaining said binding molecules.
Patent AU-2020274103-A1 (AU)
Title: Medical device having asymmetric bending
Inventor: POWELL SEAN
IPC: A61B1/005
Filed: 2020-05-13
Abstract: An articulation joint includes proximal links, distal links, and intermediate links connecting the proximal and distal links. The articulation joint has a straight configuration along a straight longitudinal axis, a first bent configuration when the articulation joint bends toward a first side of the longitudinal axis, and a second bent configuration when the articulation joint bends toward a second side of the longitudinal axis, opposite to the first side. When the articulation joint is in the straight configuration, a first gap is defined at the first side between adjacent proximal links, and the adjacent proximal links contact each other at the second side, a second gap is defined at each of the first side and the second side between adjacent distal links, and a third gap is defined at the first side between adjacent intermediate links, and adjacent intermediate links contact each other at the second side.
Patent AU-2020282382-A1 (AU)
Title: Fabrics having improved moisture transport properties
Inventor: LAU CHUN KEE
IPC: D03D15/00
Filed: 2020-05-26
Abstract: The present invention provides a fabric comprising or consisting of: a first yam comprising a fiber blend of modal and polyester; a second yam comprising spandex; and a third yam comprising polyester. The polyester in the fiber blend may have a cross-section such as X-shape, M-shape, I-shape, honeycomb-shape, Y -shape, U-shape or O-shape that creates a plurality of spaces along the length of the first yam that facilitate a capillary action. The modal in the fiber blend may have a cross-section that is substantially rectangular.
Patent AU-2020287391-A1 (AU)
Title: Synthesis of adsorption materials
Inventor: VAUGHAN JAMES
IPC: B01J37/03
Filed: 2020-05-08
Abstract: A process for producing zeolites comprising: a) calcining a clay material to form an amorphous material from clay components in the clay material, b) leaching the material from step (a) in a leaching solution to produce a solution containing dissolved aluminium and dissolved silica and a solid residue, c) separating the solid residue from the solution, and d) crystallising zeolites from the solution from step (c).
Patent AU-2020293084-A1 (AU)
Title: Device and system for remote regulation and monitoring of drug delivery and method of same
Inventor: BANOV JACOB
IPC: G16H20/10
Filed: 2020-06-09
Abstract: A device for patient self-administration of a prescribed medication. The quantity of doses in the device, the quantity of prescribed medication comprising each individual dose, and the dosing schedule, are determined and controlled solely by a health care provider (HCP). In accordance with a prescribed dosing schedule, the device makes available for administration the precise quantity of prescribed medication constituting an individual dose. The patient has no control over the prescription parameters utilized by the device. Preferably, the device also has a monitored subassembly which detects and transmits relevant device information to a remote management system accessible to the HCP, including detected attempts to alter, access, control or otherwise tamper with the device beyond its prescribed use. Advantageously, HCPs may render sufficient oversight and control over the device and its use to mitigate the risks associated with patients self-administering potentially dangerous or abusable medication without direct, in-person supervision.
Patent AU-2020296809-A1 (AU)
Title: Crosslinked synthetic polymer-based reservoir drilling fluid
Inventor: EYAA ALLOGO CLOTAIRE-MARIE
IPC: E21B43/12
Filed: 2020-06-09
Abstract: Branched and crosslinked polymeric fluid loss control agents and methods are provided that have at least one acrylamide-based monomer, at least one sulfonated anionic monomer, and at least one crosslinking monomer. The at least one acrylamide-based monomer and the at least one sulfonated anionic monomer are crosslinked. The branched and crosslinked polymeric fluid loss control agents have between 50 and 99 mol % of the at least one acrylamide-based monomer, between 1 and 30 mol % of the at least one sulfonated anionic monomer, and between 0.1 and 10 mol % of the at least one crosslinking monomer.
Patent AU-2020356209-A1 (AU)
Title: Signaling of picture header in video coding
Inventor: HENDRY FNU
IPC: H04N7/12
Filed: 2020-08-05
Abstract: A method of decoding is provided. The method includes receiving a video bitstream including a picture unit (PU), where any decoding capability information (DCI) network abstraction layer (NAL) unit, video parameter set (VPS) NAL unit, sequence parameter set (SPS) NAL unit, or picture parameter set (PPS) NAL unit referred to by the PU precedes a picture header (PH) NAL unit of the PU and a first video coding layer (VCL) NAL unit of the PU; and decoding a coded picture from the PU to obtain a decoded picture.
Patent AU-2020358774-A1 (AU)
Title: A method for obtaining a lignin oil composition using a compressed gas and acid assisted process
Inventor: BOOT MICHAEL DIRK
IPC: C07G1/00
Filed: 2020-09-30
Abstract: The present invention relates to a process for the production of a liquid lignin composition, in particular to a method for obtaining a lignin composition using a compressed gas and acid assisted process, wherein a lignocellulosic biomass feedstock is treated with a polar organic solvent using an inorganic acid to assist in the release of lignin into the polar organic solvent and the use of compressed gas to keep the polar organic solvent in its liquid phase.
Patent AU-2020366237-A1 (AU)
Title: Self-microemulsifying multi-deliverable systems
Inventor: SHADE CHRISTOPHER W
IPC: A61K47/44
Filed: 2020-10-18
Abstract: Compositions in the form of oil-based solutions that form oil-in-water (OIW) microemulsions in the aqueous environment of the GI tract when taken orally
Patent AU-2020376541-A1 (AU)
Title: Method for estimating surface tension of coal and method for producing coke
Inventor: IGAWA DAISUKE
IPC: C10B57/04
Filed: 2020-10-14
Abstract: Provided is a method for conveniently estimating coal surface tension.　This method for estimating coal surface tension comprises performing multiple regression analysis of the total inert quantity and physical values representing the surface tension and rank of coalification for a plurality of brands of coal to create a regression formula in advance that uses a criterion variable as the coal surface tension and that includes the physical values and the total inert quantity as explanatory variables, measuring the total inert quantity and the physical value of the coal for estimating surface tension, and calculating the coal surface tension using the measured physical values, the total inert quantity, and the regression formula.
Patent AU-2020379335-A1 (AU)
Title: Resource operation plan creation support device, resource operation plan creation support method, and program
Inventor: MAEKAWA YUKI
IPC: B61L27/00
Filed: 2020-09-10
Abstract: A resource operation plan creation support device 1 comprises: a training information storage unit (storage unit 13) that stores plan result information of an existing operation arrangement plan; a route recommendation processing unit 110 that, as a pre-training function, generates a route recommendation model that is a model for recommending a route; a plan creation processing unit (operation arrangement plan creation processing unit 120) that, as a plan creation function, selects a route template appropriate for a formation to be planned and creates an operation arrangement plan on the basis of the route recommendation model generated by the route recommendation processing unit 110; and a screen processing unit 140 that outputs a plan result display screen 147 which displays the operation arrangement plan created by the plan creation processing unit.
Patent AU-2020405289-A1 (AU)
Title: Methods of enhancing and expediting expression of antibodies
Inventor: NGO KATHY
IPC: C12N9/22
Filed: 2020-12-15
Abstract: This application describes cells, systems, and molecular engineering methods using CRISPR/Cas complexes for targeted activation of endogenous master transcriptional regulatory elements (MTRE) such as PRDM1, XBP1 and IRF4, to generate high productivity antibody production in production cell lines such as CHO and NSO cells. These incorporate the inclusion of the Cas accessory proteins, design of multiple guide RNAs (gRNA), and unique multiplexing of these components using, e.g., lenti viral transfection to induce increased transcription and translation of antibody genes under the control of the MTRE. The methods result in synergies increasing monoclonal antibody production by these modified cell lines. While a significant increase in productivity is demonstrated by this method of activation, further increase in productivity can be accomplished by genetic transfer of additional copies of MTREs.